CODX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Co-Diagnostics Inc (CODX) is not a good buy for a beginner, long-term investor at this time. The stock faces significant challenges, including a recent downgrade, delisting concerns, and weak financials. While there is some revenue growth, the company is not profitable, and its gross margin has significantly declined. Additionally, there are no strong technical or trading signals to support an immediate investment.
The MACD is positive and expanding, suggesting some bullish momentum. However, the RSI is neutral, and the moving averages are bearish, indicating an overall downward trend. The stock is trading near its pivot level of 1.463, with resistance at 1.559 and support at 1.368.
Revenue increased by 76.74% YoY in Q4 2025, indicating some growth potential.
The company has been downgraded to Hold due to delisting concerns. It faces challenges in accessing capital markets, which could hinder its growth. Gross margin has dropped significantly (-82.15% YoY), and the company remains unprofitable with a negative EPS of -13.67.
In Q4 2025, revenue increased by 76.74% YoY to 263,922. However, net income remains negative at -25,745,725, despite a 133.39% YoY improvement. EPS improved by 27.52% YoY but is still negative at -13.67. Gross margin dropped significantly to -55.33%.
Maxim downgraded Co-Diagnostics to Hold from Buy due to delisting concerns. While the firm sees potential in the company's technology and products, the delisting and capital access challenges pose significant risks.
